ORIGINAL RESEARCH article
Front. Neurol.
Sec. Neurogenetics
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1623314
Expanding the spectrum of white matter abnormalities in Wolfram syndrome: A retrospective review
Provisionally accepted- 1Montreal Neurological Institute, Montreal, Canada
- 2Washington University School of Medicine, St Louis, United States
- 3The Hospital for Sick Children (SickKids), Toronto, Canada
- 4Rabin Medical Center—Beilinson Hospital, Petach Tikva, Israel
- 5Eskisehir City Hospital, Eskişehir, Türkiye
- 6Chiba University, Chiba, Japan
- 7University of Naples “Federico II”, Naples, Italy
- 8IRCCS San Raffaele Hospital, Milan, Italy
- 9Royal Perth Hospital, Perth, Australia
- 10Washington University School of Medicine, St. Louis, United States
- 11Pitié-Salpêtrière University Hospital, Paris, France
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background and Objectives Wolfram syndrome (WFS) is a genetic disorder mainly caused by pathogenic variants in the WFS1 gene. It is characterized clinically by optic atrophy (OA), diabetes mellitus (DM), sensorineural hearing loss (SNHL), diabetes insipidus (DI), and variable neurological/psychiatric symptoms. WFS typically manifests before age 20 and progresses into adulthood. Classical neuroradiological features include cerebellar and/or brainstem atrophy as well as white matter abnormalities ranging from small, ovoid lesions to diffuse, symmetrical changes along the visual pathway. Following the identification of multifocal, progressive white matter abnormalities that prompted the consideration of multiple sclerosis (MS) in two molecularly confirmed WFS subjects, we sought to verify whether MS-like lesions constitute a novel WFS-associated MRI pattern. Methods We conducted an international multicenter retrospective study of the clinical, genetic, and radiological data from 17 unrelated WFS subjects. Results Seven subjects (7/17; 41%) showed at least one focal white matter lesion evocative of MS. Among these seven, three fulfilled the McDonald radiological criteria of dissemination in space and time, suggesting an inflammatory demyelinating process. All subjects reviewed in the study had at least one of the classical WFS MRI features. Conclusions Our report expands the WFS spectrum of white matter involvement to include progressive, seemingly inflammatory demyelinating lesions. While we cannot exclude the possibility of a WFS-MS dual diagnosis in some cases, the role of WFS1 in myelination suggests a selective white matter vulnerability in WFS. Our findings suggest that follow up MRI should be recommended to adult subjects with WFS. Further identification and longitudinal study of adult WFS subjects is required to confirm whether a WFS molecular diagnosis confers susceptibility to the development of MS.
Keywords: Wolfram (DIDMOAD) syndrome, Multiple Sclerosis, White matter (WM), Rare Diseases, genetic mimickers of MS
Received: 05 May 2025; Accepted: 15 Oct 2025.
Copyright: © 2025 Simo, Lugar, Miller, Wilf-Yarkoni, Goldberg, Kocaağa, Ito, Cocozza, Frontino, Baldoli, Benbachir, Ashton, Rouleau, Hershey, Nadjar and La Piana. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Roberta La Piana, roberta.lapiana@mcgill.ca
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.